Dual-Labeled Time-Resolved Immunofluorometric Assay for the Simultaneous Quantitative Detection of Hepatitis B Virus Antigens in Human Serum

[1]  T. Asselah,et al.  HBsAg quantification to predict natural history and treatment outcome in chronic hepatitis B patients. , 2013, Clinics in liver disease.

[2]  T. Le,et al.  Simultaneous detection of sulfamethazine and sulfaquinoxaline using a dual-label time-resolved fluorescence immunoassay , 2013, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[3]  Tian-Cai Liu,et al.  Development of a dual-label time-resolved fluoroimmunoassay for the detection of α-fetoprotein and hepatitis B virus surface antigen. , 2013, Luminescence : the journal of biological and chemical luminescence.

[4]  K. Migita,et al.  Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[5]  S. Ahn,et al.  Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir , 2011, Hepatology.

[6]  Bin Zhou,et al.  Simultaneous detection of deoxynivalenol and zearalenone by dual-label time-resolved fluorescence immunoassay. , 2011, Journal of the science of food and agriculture.

[7]  S. Lewin,et al.  Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers , 2010, Hepatology.

[8]  P. Komolmit,et al.  Comparison between quantitative hepatitis B surface antigen, hepatitis B e‐antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon‐α‐2b therapy in hepatitis B e‐antigen‐positive chronic hepatitis B , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

[9]  P. Marcellin,et al.  Chronic hepatitis B: back to the future with HBsAg , 2009, Expert review of anti-infective therapy.

[10]  Y. Liaw.  Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. , 2009, Journal of hepatology.

[11]  J. Hoofnagle,et al.  Evaluation of the patient with hepatitis B , 2009, Hepatology.

[12]  P. Marcellin,et al.  HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa‐2a for HBeAg‐positive chronic hepatitis B , 2008, Hepatology.

[13]  S. Louisirirotchanakul,et al.  Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants , 2007, Medical Microbiology and Immunology.

[14]  A. Tamori,et al.  Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers , 2005, Journal of medical virology.

[15]  D. Ganem,et al.  Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.

[16]  Yoshinori Iwatani,et al.  Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. , 2004, Journal of virological methods.

[17]  H. Kumada,et al.  [Chronic hepatitis B]. , 2001, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[18]  Schalm,et al.  Interferon‐α therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy , 2000, Journal of viral hepatitis.

[19]  Sheng-Nan Lu,et al.  Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection , 1999, Cancer.

[20]  A. Osterhaus,et al.  Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B , 1997, Journal of medical virology.

[21]  R. D. de Man,et al.  Quantitative measurement of HBeAg in chronic hepatitis B: A comparison between a radioimmunoassay a fluorescence ELISA and a chemiluminescence ELISA , 1995, Journal of medical virology.

[22]  K. Schechtman,et al.  Monitoring of antiviral therapy with quantitative evaluation of hbeag: A comparison with HBV DNA testing , 1993, Hepatology.

[23]  I. Hemmilä,et al.  Analytical application of the co-fluorescence effect in detection of europium, terbium, samarium and dysprosium with time-resolved fluorimetry. , 1992, Talanta.

[24]  I Hemmilä,et al.  Lanthanides as probes for time-resolved fluorometric immunoassays. , 1988, Scandinavian journal of clinical and laboratory investigation.